News World Gilead's COVID-19 antiviral remdesivir gets conditional EU clearance

Gilead’s COVID-19 antiviral remdesivir gets conditional EU clearance

The European Commission said on Friday it had given conditional approval for the use of antiviral remdesivir in severe COVID-19 patients following an accelerated review process, making it the region’s first therapy to be authorised to treat the virus.

The move comes just a week after the European Medicines Agency (EMA) gave its go-ahead for the drug produced by Gilead Sciences to be use in adults and adolescents from 12 years of age who are also suffering from pneumonia and require oxygen support.

It also comes just days after the company allocated nearly all of its supply of the antiviral to the United States over the next three months, stirring concerns about availability elsewhere.

“We will leave no stone unturned in our efforts to secure efficient treatments or vaccine against the coronavirus,” said Stella Kyriakides, EU Commissioner for Health and Food Safety, in a statement.

The Commission said on Wednesday it was in negotiations with Gilead to obtain doses of remdesivir for the 27 European Union countries.

A conditional marketing authorisation is one of the EU regulatory mechanisms created to facilitate early access to medicines that fulfil an unmet medical need, including those for emergency situations in response to public health threats such as the current pandemic, the Commission said.

The agency reviews data as they become available on a rolling basis, while development is still ongoing. The EMA’s rolling review begun at the end of April.

Remdesivir is in high demand after the intravenously-administered medicine helped to shorten hospital recovery times in a clinical trial. It is believed to be most effective in treating COVID-19 patients earlier in the course of disease than other therapies like the steroid dexamethasone.

Still, because remdesivir is given intravenously over at least a five-day period it is generally being used on patients sick enough to require hospitalisation.

(Reuters)

Top Stories

Bus in Nicosia rolls forward after driver jumped out, causes havoc (PHOTOS)

A bus on Diagorou Street in the heart of Nicosia on Thursday morning rolled forward after the driver had just jumped out. No one was...

National Guard left with just 20 military doctors

The National Guard is left with only 20 military doctors amidst concerns that all will quit if they are not allowed to privately practice...

New Cyprus-France defence pact came in effect on August 1

A defence cooperation agreement signed in April 2017 between Cyprus and France came into effect on August 1, an official press release said on...

Doctors say Turkish COVID-19 outbreak worse than reported

Doctors in Turkey's coronavirus hotspots say hospitals are filling up with more cases than are reflected in the official nationwide count, which resurged above 1,000...

Russian shipowner linked with Beirut port blast holds no Cypriot passport

The Russian owner of the impounded ship where 2,700 tonnes of ammonium nitrate were taken from and stored in the now devastated port of...

Taste

Octopus ‘Kathisto’ (or Octopus braised in Wine)

Ingredients: 1/2 cup Greek extra virgin olive oil 2 medium onions, chopped fine 1 large octopus, about 2kg (cleaned and kept whole) 3/4 cup dry red wine 1/3 cup...

Homemade lemonade

Ingredients: 1 cup lemon juice 1 cup sugar Method: Thoroughly wash the lemons with soap and warm water. Roll each lemon with the palm of your hand, pressing...

‘Striftaria’ mini cheese pies

Ingredients 1 ½ cup milk 2 tbsps. flour 4 tsps. of butter 3 eggs, slightly beaten + 1 extra with 1 tbs. of milk for spreading 1 pack of...

Mini potato canapes baked on salt

Ingredients Serves: 12 1kg small Cypriot potatoes rock salt, as needed 250g salted butter 300ml full fat cremé frâiche 1 pot cod or salmon roe Method Prep:20min › Cook:35min › Ready in:55min Take...